Literature DB >> 10810650

Potential applications of tissue inhibitor of metalloproteinase (TIMP) overexpression for cancer gene therapy.

A H Baker1, M Ahonen, V M Kähäri.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10810650     DOI: 10.1007/0-306-46817-4_41

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  7 in total

Review 1.  A case of tumor betrayal: biphasic effects of TIMP-1 on Burkitt's lymphoma.

Authors:  L Yan; M A Moses
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

2.  Inhibition of metastatic progression of SSTR2 gene transfection mediated by adenovirus in human pancreatic carcinoma cells.

Authors:  Yanping Feng; Tao Huang; Jun Gao; Qing Chang; Renyi Qin
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

3.  Tissue inhibitor of matrix metalloproteinase-2 in nasopharyngeal carcinoma.

Authors:  Amr Ahmed El Badry; Amal Abou El-Fadle; Abdel Latif El-Balshy
Journal:  MedGenMed       Date:  2007-07-03

Review 4.  Structural aspects of the metzincin clan of metalloendopeptidases.

Authors:  F Xavier Gomis-Rüth
Journal:  Mol Biotechnol       Date:  2003-06       Impact factor: 2.695

5.  Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).

Authors:  Joanna R Worley; Philip B Thompkins; Meng H Lee; Mike Hutton; Paul Soloway; Dylan R Edwards; Gillian Murphy; Vera Knäuper
Journal:  Biochem J       Date:  2003-06-15       Impact factor: 3.857

6.  Luteolin reduces inflammation in Staphylococcus aureus-induced mastitis by inhibiting NF-kB activation and MMPs expression.

Authors:  Ying-Fang Guo; Nian-Nian Xu; Weijing Sun; Yifan Zhao; Cheng-Ye Li; Meng-Yao Guo
Journal:  Oncotarget       Date:  2017-04-25

7.  Matrix metalloproteinase-2 and -9 and tissue inhibitor of metalloproteinase-1 and -2 in sera and urine of patients with renal carcinoma.

Authors:  Angelina DI Carlo
Journal:  Oncol Lett       Date:  2013-12-11       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.